Development of a handheld rapid air sensing system to monitor and quantify SARS-CoV-2 in aerosols in real-time

开发手持式快速空气传感系统，实时监测和量化气溶胶中的 SARS-CoV-2

• 批准号: 10273983
• 负责人: Ricardo Mancebo
• 金额: $ 272.32万
• 依托单位: GENENDEAVOR, LLC
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-20 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10273983
• 关键词: 2019-nCoV; Address; Aerosols; Air; Applications Grants; Aspirate substance; Benchmarking; Biophotonics; COVID-19; COVID-19 detection; COVID-19 monitoring; COVID-19 pandemic; COVID-19 patient; Cell Culture Techniques; Cell Nucleus; Cessation of life; Chemicals; Collection; Communities; Contact Tracing; Country; DNA; Data; Detection; Development; Devices; Dose; Drops; Environment; Enzyme Inhibitor Drugs; Enzymes; Goals; Guidelines; Handwashing; Health; Hospitals; Hour; Human; Individual; Interdisciplinary Study; Investigation; Knowledge; Laboratories; Lead; Ligation; Lung; Masks; Measurement; Measures; Methods; Monitor; Nasal cavity; Onset of illness; Performance; Photons; Polymerase Chain Reaction; Predisposition; Preparation; Process; Protocols documentation; Quarantine; RNA; RNA-Directed DNA Polymerase; Reaction Time; Reading; Reagent; Reporting; Research; Research Proposals; Reverse Transcription; Risk; Risk Management; Role; SARS-CoV-2 infection; SARS-CoV-2 transmission; Safety; Sampling; Schools; Severity of illness; Signal Transduction; Social Distance; Speed; Standardization; Symptoms; System; Technology; Testing; Time; Uncertainty; Viral; Viral Load result; Virus; Virus Inactivation; Workplace; aerosolized; air monitoring; air sampling; base; chemical kinetics; design; detection platform; disease transmission; epidemiology study; foot; genomic RNA; high risk; human coronavirus; infection rate; infection risk; innovation; insight; knowledge base; laboratory equipment; monitoring device; novel; particle; photon-counting detector; portability; prevent; real time monitoring; sensor; solid state electronics; tissue culture; tool; transmission process; viral detection

Project Summary The ability to rapidly monitor SARS-CoV-2 in aerosol—drop particles <5 μm in size that evaporate into droplet nuclei and become suspended in air—at the point of presentation is critical to managing the risk of infection by airborne transmission as people return to their communities, workplaces, and schools during the COVID-19 pandemic. However, current enzyme-based methods lack sensitivity, speed, simplicity, and require lab equipment—hence, lack the capability for real-time point-of-presentation (POP) monitoring. In the absence of a real-time POP monitoring capability, SARS-CoV-2 transmission remains poorly understood. In this application, a multidisciplinary research approach that integrates innovations in rapid-kinetic chemical auto-ligation, non- enzymatic isothermal signal amplification, solid-state electronics, and biophotonics is proposed to enable the development of a novel air monitoring system (AMS) that detects and quantifies aerosolized SARS-CoV-2 at the point of presentation in real-time. Recent advances in viral culturing protocols, air sampling technology, and single-photon detection capability will provide the framework for a collaborative research endeavor to establish a new paradigm to address the knowledge gap between the spread of COVID-19 and SARS-CoV-2 aerosol transmission. Therefore, the proposal is aimed at transforming the way COVID-19 is currently researched by providing a tool to enable unparalleled studies that will significantly advance the current knowledgebase. These transformative studies could ultimately guide a new field of investigations that lead to a better understanding of COVID-19 spread, such as viral exposure vs. risk, viral decay rate vs. infectivity, and viral load vs. infectious dose in SARS-CoV-2 airborne transmission. At a minimum, the proposed three research objectives will provide a basic understanding of COVID-19 aerosol transmission. Firstly, current air sampling systems use a multi-step workflow that takes several hours to complete and requires lab equipment, reagents, and significant hands-on time. The goal of objective 1 is to combine air sampling and detection into a one-step real-time POP AMS device that yields SARS-CoV-2 quantification results in less than 5 minutes, without lab equipment or reagents. Secondly, viral inoculum, or initial dose of virus, aspirated into the nasal cavity and lungs has been associated with disease onset and severity. The goal of objective 2 is to optimize and validate AMS to correlate readings from the air monitoring device with tissue-culture infectious dose (TCID50) and reverse transcription polymerase chain reaction (RT-PCR) quantities. These parameters can then later be applied to Human studies to determine the Human infectious dose of SARS-CoV-2 by aerosol transmission. Thirdly, field-based testing in hospitals will provide a means to beta test AMS performance in high-risk environments. The goal of objective 3 is to calibrate AMS measurements with RT-PCR cycle-threshold (Ct) values and cell-culture TCID50 viability results and then benchmark with results from high-risk environments taken from around the world to correlate SARS-CoV-2 aerosol concentrations with global infection rate, as a potential for establishing threshold levels.

项目摘要 快速监测蒸发成液滴的气雾剂颗粒中SARS-CoV-2的能力 细胞核并悬浮在空气中--在发病时对控制感染风险至关重要。 新冠肺炎期间，人们返回社区、工作场所和学校时通过空气传播 大流行。然而，目前基于酶的方法缺乏灵敏度、快速、简单且需要实验室 设备--因此，缺乏实时监控呈现点(POP)的能力。在缺少 对于POP的实时监测能力，SARS-CoV-2的传播仍然知之甚少。在此应用程序中， 一种多学科的研究方法，整合了快速动力学化学自动配位、非 酶等温信号放大、固态电子学和生物光子学被提出以使 新型气雾化SARS-CoV-2空气监测系统的研制 实时演示的要点。病毒培养方案、空气采样技术和 单光子探测能力将为合作研究努力提供框架，以建立 解决新冠肺炎传播和SARS-CoV-2气雾剂之间知识差距的新范式 变速箱。因此，该提案旨在转变美国政府目前对新冠肺炎的研究方式。 提供一种工具来实现无与伦比的研究，这将极大地推进当前的知识库。这些 变革性研究最终可能指导一个新的调查领域，从而更好地理解 新冠肺炎传播，如病毒暴露与风险、病毒衰减率与传染性、病毒载量与传染性 SARS-CoV-2通过空气传播的剂量。至少，拟议的三个研究目标将提供 对新冠肺炎气溶胶传播有基本了解。首先，目前的空气采样系统使用多步骤 需要几个小时才能完成并需要实验室设备、试剂和大量实际操作的工作流程 时间到了。目标1的目标是将空气采样和检测结合到一步实时POP AMS中 SARS-CoV-2定量检测设备在不到5分钟的时间内完成，无需实验室设备或试剂。 其次，吸入鼻腔和肺部的病毒疫苗或初始剂量的病毒与 与疾病的发病和严重程度有关。目标2的目标是优化和验证AMS以关联读数 来自空气监测装置的组织培养感染剂量(TCID50)和逆转录 聚合酶链式反应(RT-PCR)定量。这些参数随后可以应用于人体研究 通过气雾剂传播测定人感染SARS-CoV-2的剂量。第三，基于现场的测试 医院将提供一种在高风险环境中测试AMS性能的方法。目标3的目标 是用RT-PCR周期阈值(Ct)值和细胞培养TCID50活性校准AMS测量 结果，然后与来自世界各地的高风险环境的结果进行基准比较，以进行关联 SARS-CoV-2气溶胶浓度与全球感染率的关系，作为建立阈值水平的可能性。